Patent search ap:("DexCom Page Inc.") AND inv:"Mark C. Brister"

71.

发明授权
Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise 有权

公开(公告)号：US10376143B2

公开(公告)日：2019-08-13

申请号：US14145404

申请日：2013-12-31

Applicant: DexCom, Inc.

Inventor： Peter C. Simpson , Robert J. Boock , Mark C. Brister , Monica A. Rixman , Kum Ming Woo , Lisa Nguyen , Seth R. Brunner , Arthur Chee , Melissa A. Nicholas , Matthew D. Wightlin , Jack Pryor , Dubravka Markovic

IPC: A61B5/00 , A61B5/145 , A61B5/1486 , A61B5/1473

Abstract: Systems and methods of use involving sensors having a signal-to-noise ratio that is substantially unaffected by non-constant noise are provided for continuous analyte measurement in a host. In some embodiments, a continuous analyte measurement system is configured to be wholly, transcutaneously, intravascularly or extracorporeally implanted.

72.

发明授权
Analyte sensor 有权

公开(公告)号：US10349873B2

公开(公告)日：2019-07-16

申请号：US15140307

申请日：2016-04-27

Applicant: DexCom, Inc.

Inventor： Apurv Ullas Kamath , Jacob S. Leach , Ying Li , Daiting Rong , Sean Saint , Peter C. Simpson , Mark C. Brister

IPC: A61B5/00 , A61B5/145 , A61B5/1486 , A61B5/1495 , C12Q1/00 , A61B5/1473 , A61M5/14 , A61M5/168 , A61M25/00 , G06F19/00 , G16H40/40

Abstract: Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.

73.

发明申请
INTEGRATED MEDICAMENT DELIVERY DEVICE FOR USE WITH CONTINUOUS ANALYTE SENSOR 审中-公开

公开(公告)号：US20190209009A1

公开(公告)日：2019-07-11

申请号：US16358552

申请日：2019-03-19

Applicant: DexCom, Inc.

Inventor： Mark C. Brister , Nelson Quintana , Antonio C. Llevares , John Michael Dobbles , Richard C. Yang , Michael Robert Mensinger

IPC: A61B5/00 , A61B5/145 , A61M5/315 , A61M5/172 , A61M5/24

CPC classification number: A61B5/0002 , A61B5/14532 , A61B5/14546 , A61B5/1486 , A61B5/4839 , A61B2560/04 , A61B2560/0406 , A61B2560/0431 , A61B2560/0443 , A61M5/003 , A61M5/1723 , A61M5/24 , A61M5/31525 , A61M2205/3561 , A61M2205/3569 , A61M2205/3592 , A61M2205/50 , A61M2205/502 , A61M2205/581 , A61M2205/582 , A61M2205/583 , A61M2209/086 , A61M2230/201 , G06F19/3468 , G16H20/17

Abstract: An integrated system for the monitoring and treating diabetes is provided, including an integrated receiver/hand-held medicament injection pen, including electronics, for use with a continuous glucose sensor. In some embodiments, the receiver is configured to receive continuous glucose sensor data, to calculate a medicament therapy (e.g., via the integrated system electronics) and to automatically set a bolus dose of the integrated hand-held medicament injection pen, whereby the user can manually inject the bolus dose of medicament into the host. In some embodiments, the integrated receiver and hand-held medicament injection pen are integrally formed, while in other embodiments they are detachably connected and communicated via mutually engaging electrical contacts and/or via wireless communication.

74.

发明授权
Transcutaneous analyte sensor 有权

公开(公告)号：US10327638B2

公开(公告)日：2019-06-25

申请号：US15798097

申请日：2017-10-30

Applicant: DexCom, Inc.

Inventor： Mark C. Brister , Paul V. Neale , Peter C. Simpson , James H. Brauker , James Patrick Thrower , Mark Shults , Rathbun K. Rhodes , Paul V. Goode, Jr. , Arnold L. Holmquist

IPC: A61B5/1473 , A61B5/1468 , A61B5/00 , A61B5/07 , A61B5/145 , H04B1/03

Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.

75.

发明授权
Dual electrode system for a continuous analyte sensor 有权

公开(公告)号：US10299712B2

公开(公告)日：2019-05-28

申请号：US15695932

申请日：2017-09-05

Applicant: DexCom, Inc.

Inventor： Mark C. Brister , James R. Petisce , Peter C. Simpson

IPC: A61B5/05 , A61B5/1486 , A61B5/145 , A61B5/1495 , A61B5/00 , B33Y80/00 , B33Y70/00

Abstract: Disclosed herein are systems and methods for a continuous analyte sensor, such as a continuous glucose sensor. One such system utilizes first and second working electrodes to measure additional analyte or non-analyte related signal. Such measurements may provide a background and/or sensitivity measurement(s) for use in processing sensor data and may be used to trigger events such as digital filtering of data or suspending display of data.

76.

发明申请
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM 审中-公开

公开(公告)号：US20180289333A1

公开(公告)日：2018-10-11

申请号：US16000748

申请日：2018-06-05

Applicant: DexCom, Inc.

Inventor： Apurv Ullas Kamath , Aarthi Mahalingam , Ying Li , Mohammad Ali Shariati , James H. Brauker , Mark C. Brister , Robert Boock

IPC: A61B5/00 , A61B5/145 , A61B5/1486 , A61B5/1495 , A61B5/01

Abstract: Systems and methods for detecting noise episodes and processing analyte sensor data responsive thereto. In some embodiments, processing analyte sensor data includes filtering the sensor data to reduce or eliminate the effects of the noise episode on the signal.

77.

发明授权
Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise 有权

公开(公告)号：US09763609B2

公开(公告)日：2017-09-19

申请号：US13732848

申请日：2013-01-02

Applicant: DexCom, Inc.

Inventor： Peter C. Simpson , Robert J. Boock , James R. Petisce , Mark C. Brister , Monica A. Rixman , Kum Ming Woo , Lisa Nguyen , Seth R. Brunner , Arthur Chee , Melissa A. Nicholas , Matthew D. Wightlin , Jack Pryor , Dubravka Markovic

IPC: A61B5/05 , A61B5/1473 , A61B5/145 , A61B5/1486 , A61B5/00

CPC classification number: A61B5/14735 , A61B5/14532 , A61B5/14546 , A61B5/1473 , A61B5/1486 , A61B5/14865 , A61B5/6848 , A61B5/7203

Abstract: Systems and methods of use involving sensors having a signal-to-noise ratio that is substantially unaffected by non-constant noise are provided for continuous analyte measurement in a host. In some embodiments, a continuous analyte measurement system is configured to be wholly, transcutaneously, intravascularly or extracorporeally implanted.